ECCO 2023

JAK inhibitors - small molecules to treat IBD

A focus on surgery and post-operative maintenance

S1P modulators - a rising class of drugs

Upadacitinib for fistulizing Crohn´s disease?

No impact of previous therapies for Upadacitinib in…

Latest update on JAK inhibition

Upadacitinib is efficacious for UC regardless of…

Mucosal healing induced by vedolizumab in chronic…

Upadacitinib works in bionaive and bio-exposed pts in…

Vedolizumab heals pouch mucosa

Long-term extension of ustekinumab in UC

S1P modulators in UC

Medium-term outcome of IBD patients diagnosed at…

Long-term duration of response with ozanimod in UC

Upadacitinib is efficient bij colitis ulcerosa,…

Studio lungo termine di ustekinumab in UC

Il prolungamento del trattamento con Ozanimod induce…

Η μεσοπρόθεσμη έκβαση ασθενών με ΙΦΝΕ που…

S1P-Modulatoren bei Colitis ulcerosa

Upadacitinib: Vortherapien spielen keine Rolle mehr bei…

Lang Termijn respons met ozanimod bij colitis ulcerosa

Anti-IL23 drugs: is it all the same?

Safety update on JAKis - new worries?

New aspects on safety of anti-TNF treatment

Etrasimod shows fast stool frequency and rectal…

Positive effects of Upadacitinib on resolution of…

Ozanimod shows good efficacy and safety profile in UC…

Ileostomy with better prognosis than pouch in PSC

Rapido controllo del sanguinamento rettale e della…

Ozanimod shows good efficacy and safety profile after…

Les antibiotiques dans la petite enfance augmentent le…

Το upadacitinib επιφέρει ύφεση των κοιλιακών…

10 years of Tofacitinib – still more lessons to learn

Is it feasible to stop anti-TNF treatment in…

Vedolizumab prevents postoperative recurrence in CD

Ileocaecal Crohn's disease - should we call the surgeon…

Enteral nutrition - food for thought!

Vedolizumab for preventing postoperative reccurence of…

Surgery in CD - resetting or not?

Surgical and post-operative management in CD

Another clue for the role of the microbiome in PSC?

Early treatment with biologics in IBD

Biologics in CD – is earlier better?

DNA methylation predicts response to biologics in IBD

Epigenetic fingerprinting - a novel tool for precision…

New drugs on the block!

Timing of surgery in Crohn's disease

Peri- and postoperative management of CD

Post-surgical Crohn's disease

Epigenetic Fingerprinting - ein neues Werkzeug für die…

Aanpak van de (post)operatieve Crohn patient

Είναι ευχερές να διακόψουμε τους αντι-TNF παράγοντες…

Biologics in CD - is earlier better?

Biosimilars

Chirurgischer Verlauf nach Morbus Crohn

Résection chirurgicale au course de la maladie de…

Postać ileocekalna choroby Crohna - czy chirurgia ma…

Vedolizumab previene la recidiva post operatoria nei…

Neue Substanzen!

Peri- und postoperatives Management bei Morbus Crohn

Another clue for the role of the microbiome in PSC?

Résection chirurgicale précoce dans la MC

Comprehensive remission - the new standard!?

Comprehensive Disease Control

Comprehensive overview of surgery in IBD

Mucosal signatures suggest a mechanism for early CD…

Our patients will be better off in the near future!

Sequencing in IBD - congress overview

New ECCO guidelines on extraintestinal manifestations…

GPX4 fueling postoperative recurrence in Crohn's…

Una vida mejor en el futuro inmediato para nuestros…

Nuove opportunità dall’applicazione dell’intelligenza…

Panoramica completa sulla chirurgia nelle malattie…

Mucosal signatures suggest a mechanism for early CD…

GPX4 fördert postoperatives Morbus Crohn Rezidiv

Sequencing nelle malattie infiammatorie cronicale…